Generx: SUMMARY COMMENTARY  Generx will initially

New Post Public Reply Private Reply Replies (1) Message Board
docj
348
Generx:

SUMMARY COMMENTARY
 Generx [Ad5FGF-4] will initially be focused on refractory angina, which represents a significant
potentially unmet medical need for ~1.2 million U.S. patients with coronary artery disease, representing
a potential addressable market of > $3.0 billion. We believe FDA approval of Generx would be high
profile and garner significant worldwide interest.
 In vitro studies identify FGF-4 as a key biologic regulatory protein that orchestrates the angiogenic
growth factor (e.g. VEGF)- mediated cascade of events required for therapeutic angiogenesis.
 Preclinical studies confirmed and optimized Generx’s receptor-mediated uptake and level of transgene
expression in the heart, and demonstrated an angiogenic mechanism of action (echocardiography).
 Human clinical studies confirmed Generx’s angiogenic mechanism of action, demonstrated increased
cardiac perfusion following a one-time treatment (SPECT imaging), and improvements in exercise
treadmill testing (ETT).
 The FDA-approved Phase 3 AFFIRM study is designed statistically, based on prior Generx clinical study
data, to meet or exceed ETT outcomes that formed the basis for FDA approval of Ranexa.
 Generx angiogenic therapy fits within the current standards of care (administered during a standard
angiography procedure), requires no special devices or training, and will be modestly priced to
maximize market adoption (aligned with stent pricing at $2k to $5k).
 Novel anti-anginal therapies are few and far between. There has been only one anti-anginal drug with a
novel mechanism of action approved by the FDA in the past half-century (Gilead’s Ranexa), which was
acquired one year following FDA approval for $1.4 billion.
 With FDA approval, Generx would be the first Gene Therapy for the treatment of “otherwise healthy
cardiac patients”, that would bring the field into mainstream cardiovascular medicine – an historic
achievement

Cardium Therapeutics Inc (CRXM) Stock Research Links

CRXM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 3

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 2

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 2

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 2

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Amwell Revolutionizes Digital Care Platforms in 2026

Updated Category News Views 2

Amwell's Bold Move in Virtual Care Funny how in today’s digital age, where everyone is glued to their screens, healthcare can still feel like trying to piece together a jigsaw puzzle with missing pieces. But Amwell seems to have cracked the code, redefining digital care delivery like few others. Just recently, they bagged Frost & Sullivan's 2026 United States Technology...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 2

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
Chris Auffenberg Buick: 1.9% APR Drives New Deals

Updated Category News Views 3

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

Continue Reading
UGREEN's MagFlow Series: A Game-Changer in Charging

Updated Category News Views 2

UGREEN Unveils a Cool Revolution in Charging Out in Foxborough, UGREEN is shaking things up at its Smart Living Launch Event. The big reveal? The MagFlow Series, their flagship wireless charging lineup, which promises faster and cooler charging than ever before. UGREEN's taking wireless charging to new heights, and that's got my attention. What Makes MagFlow Stand Out...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 1

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading

Top 5 Most Recently Viewed Articles

Simmons First National Stock Surges to New Heights at $23.75

Updated Category News Views 81

Simmons First National Stock Reaches New Highs Simmons First National Corporation (SFNC) recently achieved a commendable 52-week high, trading at $23.75. This milestone reflects a remarkable 64.74% increase over the past year, indicating robust investor confidence in the bank holding company's performance. The significant uptick in stock price illustrates the strong...

Continue Reading
Asembia Launches Groundbreaking Digital Retail Network for Patients

Updated Category News Views 337

Asembia Unveils the ASPN Digital Retail Network™ Asembia is excited to introduce the ASPN Digital Retail Network™, a revolutionary network designed to improve patient access to prescriptions. This expansive network brings together various pharmacy types, including retail, digital, and independent pharmacies, pushing the boundaries of how prescriptions are processed....

Continue Reading
Insights into Comfort Systems USA's Rising Short Interest Trends

Updated Category News Views 86

Examining the Surge in Short Interest for Comfort Systems USA Comfort Systems USA (NYSE: FIX) has seen a significant jump in its short interest, with a rise of 5.63% since the last report. The company has now revealed that about 553 thousand shares are being sold short, which accounts for roughly 2.25% of all available shares for trading. This increase suggests a...

Continue Reading
US Cleaning Services Market Growth Driven by Multifamily Homes

Updated Category News Views 143

Exploring the Growth of the US Cleaning Services Market The commercial and residential cleaning services market in the US is on the brink of significant growth. It's projected to increase by USD 36.81 billion in the coming years, fueled by the rising popularity of multifamily dwellings. As we delve deeper, we’ll explore what factors are propelling this expansion and...

Continue Reading
Invesco High Income Trust II and Senior Income Trust Announce Dividends

Updated Category News Views 125

Invesco High Income Trust II and Senior Income Trust Announce Dividends The Boards of Trustees for both Invesco High Income Trust II and Invesco Senior Income Trust have recently declared important dividends, marking a significant event for investors in these funds. Details of the Dividend Declaration The Funds have revealed critical dividend dates: the ex-date and record...

Continue Reading